Evidence map›Paper›PMID 42090385›Full record

ArticlePloS one2026

Robust disease prognosis via diagnostic knowledge preservation: A sequential learning approach.

Haresh Rengaraj Rajamohan, Yanqi Xu, Weicheng Zhu, Richard Kijowski, Kyunghyun Cho, Krzysztof J Geras, Narges Razavian, Cem M Deniz

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Haresh Rengaraj RajamohanCenter for Data Science, New York University, New York, New York, United States of America.ORCID https://orcid.org/0000-0002-7926-9090
Yanqi XuCenter for Data Science, New York University, New York, New York, United States of America.ORCID https://orcid.org/0009-0006-0744-4183
Weicheng ZhuCenter for Data Science, New York University, New York, New York, United States of America.
Richard KijowskiDepartment of Radiology, Hospital for Special Surgery, New York, New York, United States of America.
Kyunghyun ChoCenter for Data Science, New York University, New York, New York, United States of America.
Krzysztof J GerasCenter for Data Science, New York University, New York, New York, United States of America.
Narges RazavianDepartment of Radiology, New York University Langone Health, New York, New York, United States of America.
Cem M DenizDepartment of Radiology, New York University Langone Health, New York, New York, United States of America.ORCID https://orcid.org/0000-0001-8809-5945

Funding

Deep Learning-based Imaging Biomarkers for Knee OsteoarthritisR01AR074453 · NIAMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI DENIZ, CEM MURAT · 2019 to 2023
$2.5M
NIAMS NIH HHS R01 AR074453
6 · The paper itself

Abstract

Accurate disease prognosis is essential for patient care but is often hindered by the scarcity of longitudinal data. This study explores deep learning training strategies that utilize large, accessible diagnostic datasets to pretrain models aimed at predicting future disease progression in knee osteoarthritis (OA), Alzheimer's disease (AD), and breast cancer (BC). While diagnostic pretraining improves prognostic task performance, naive fine-tuning for prognosis can cause 'catastrophic forgetting,' where the model's original diagnostic accuracy degrades, a significant patient safety concern in real-world settings. To address this, we propose a sequential learning strategy with experience replay. We used cohorts with knee radiographs, brain MRIs, and digital mammograms to predict 4-year structural worsening in OA, 2-year cognitive decline in AD, and 5-year cancer diagnosis in BC. Our results showed that diagnostic pretraining on larger datasets improved prognosis model performance compared to standard baselines, boosting both the Area Under the Receiver Operating Characteristic curve (AUROC) (e.g., Knee OA external: 0.770 vs 0.747; Breast Cancer: 0.874 vs 0.848) and the Area Under the Precision-Recall Curve (AUPRC) (e.g., Alzheimer's Disease: 0.752 vs 0.683). Additionally, a sequential learning approach with experience replay achieved prognostic performance comparable to dedicated single-task models (e.g., Breast Cancer AUROC 0.876 vs 0.874) while also preserving diagnostic ability. This method maintained high diagnostic accuracy (e.g., Breast Cancer Balanced Accuracy 50.4% vs 50.9% for a dedicated diagnostic model), unlike simpler multitask methods prone to catastrophic forgetting (e.g., 37.7%). Our findings show that leveraging large diagnostic datasets is a reliable and data-efficient way to enhance prognostic models while maintaining essential diagnostic skills.

Indexed as

Alzheimer DiseaseBreast NeoplasmsDeep LearningOsteoarthritis, KneeDisease ProgressionFemaleHumansMagnetic Resonance ImagingPredictive Learning ModelsPrognosisROC Curve

Identifiers

PMID42090385
PMCPMC13148697

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.